[Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences].
Robak
T
T
Krykowski
E
E
Matusewicz
W
W
Olszańska-Skorek
T
T
Urbańska-Ryś
H
H
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged
D003561:Cytarabine; D005047:Etoposide; D008727:Methotrexate
Duze dawki cytarabiny, etopozydu i metotreksatu (program CEM) w leczeniu ostrej białaczki limfoblastycznej u dorosłych, opornej na konwencjonalne leczenie i w nawrotach.